ClinicalMetric / Countries / Finland / alpha 1 antitrypsin deficiency
← 🇫🇮 Finland Trials
🇫🇮 Finland Country × Condition

alpha 1 antitrypsin deficiency Clinical Trials in Finland

Active clinical trials for alpha 1 antitrypsin deficiency with research sites in Finland. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 3 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇫🇮 Finland

Active Trials in Finland (1)

NCT04204252 Phase 3
Recruiting

Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"

Enrollment
220 pts
Country
🇫🇮 Finland
Kamada, Ltd.
View Trial →

Frequently Asked Questions

How many alpha 1 antitrypsin deficiency clinical trials are active in Finland?
There are currently 1 active clinical trials for alpha 1 antitrypsin deficiency with sites in Finland, of which 1 are actively recruiting patients.
How can I join a alpha 1 antitrypsin deficiency clinical trial in Finland?
To join a alpha 1 antitrypsin deficiency clinical trial in Finland, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Finland directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are alpha 1 antitrypsin deficiency trials in Finland?
Active alpha 1 antitrypsin deficiency trials in Finland span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Finland Trials → Global alpha 1 antitrypsin deficiency Trials → All Countries → All Trials →